Jietai Technology-P (07666) officially joined the Hong Kong Stock Connect to open a channel for mainland investors to participate

The Zhitong Finance App learned that the Shanghai Stock Exchange issued a notice after the market on September 4. According to the relevant provisions of the “Shanghai Stock Exchange Shanghai-Hong Kong Stock Exchange Business Implementation Measures”, Jietai Technology-P (07666) was officially transferred to the Hong Kong Stock Exchange's securities list. The adjustment will take effect on September 7 (Monday). This means that mainland investors can now directly trade Jietai Technology through the Shanghai-Shenzhen-Hong Kong Stock Connect, officially unlocking southbound capital.

In the first half of this year, Jietai Technology achieved revenue of 154 million yuan, a sharp increase of 13339% over the previous year, exceeding 47% of last year's annual revenue. During the reporting period, Jietai Technology also realized the external industrial infrastructure-level application of NanoForge, promoting cooperation between the company's AItem artificial intelligence formulation innovation platform and Hengrui Pharmaceutical; signed an exclusive license agreement with BioThunder AG, which obtained an exclusive license fee of 15 million yuan, covering up to 10 candidate products; and also signed a strategic cooperation agreement with Propharmaceuticals to jointly build an “AI+CDMO” pharmaceutical innovation ecosystem.